Publicacións en colaboración con investigadores/as de Hospital Universitario de Salamanca (242)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  3. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 58

  4. Clinical, Histopathologic and Genetic Features of Rhabdoid Meningiomas

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  5. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217

  6. Diagnosis and Treatment of Pleural Effusion. Recommendations of the Spanish Society of Pulmonology and Thoracic Surgery. Update 2022

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 27-35

  7. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  8. Effectiveness and Safety of an Outpatient Program for Percutaneous Left Atrial Appendage Occlusion

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  9. Efficacy and Safety of Indwelling Catheter for Malignant Pleural Effusions Related to Timing of Cancer Therapy: A Systematic Review

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 566-574

  10. Iberian experience with PASCAL transcatheter edge-to-edge repair for mitral valve regurgitation

    Revista Espanola de Cardiologia, Vol. 76, Núm. 1, pp. 25-31

  11. Imaging for LAA Interventions

    Mastering Structural Heart Disease (wiley), pp. 425-432

  12. Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

    Annals of Hematology, Vol. 102, Núm. 2, pp. 429-437